TRACON Pharmaceuticals, Inc. (TCON) News
Filter TCON News Items
TCON News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TCON News Highlights
- For TCON, its 30 day story count is now at 2.
- Over the past 1 day, the trend for TCON's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about TCON are PRE, NOV and TOP.
Latest TCON News From Around the Web
Below are the latest news stories about TRACON PHARMACEUTICALS INC that investors may wish to consider to help them evaluate TCON as an investment opportunity.
Why Is Tracon Pharmaceuticals (TCON) Stock Up 19% Today?Tracon Pharmaceuticals stock is rising higher on Tuesday as investors in TCON react to news of a new licensing agreement. |
Why Is LQR House (LQR) Stock Up 30% Today?LQR House stock is rising higher on Tuesday after the company announced plans to repurchase up to $2 million worth of its shares. |
Why Is Reliance Global (RELI) Stock on the Move Today?Reliance Global stock is on the move Tuesday after the company first announced, and then withdrew, a public offering for RELI shares. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! |
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront PaymentSAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform (PDP) to advance its pipeline of novel targeted cancer therapeutics and to partner with other life science companies, today announced it has licensed its proprietary PDP of CRO-independent clinical research to a clinical stage biotech company for a $3.0 million upfront payment. “We are excited |
JOBY Stock Alert: Joby Aviation Scores New Tax Credit for Ohio FactoryJoby Aviation stock is getting a boost on Monday as investors in the company react to a new tax credit offer to build a factory in Ohio. |
Why Is Tracon Pharmaceuticals (TCON) Stock Down 22% Today?TCON stock is falling on Monday as the company's shares give up their gains from an earnings rally on Friday. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayPre-market stock movers are worth checking out on Monday as we cover all of the biggest gainers and losers this morning! |
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call TranscriptTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals Third Quarter 2023 Earnings Conference Call. [Operator Instructions] During today’s call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, financing opportunities, […] |
Why Is Tracon Pharmaceuticals (TCON) Stock Up 130% Today?Tracon Pharmaceuticals stock is rising higher on Friday with heavy trading of TCON despite the company missing estimates in Q3 2023. |